@FierceBiotech: Still trending: FDA OKs 5 blockbusters in slow start to 2013 drug approvals. Report | Follow @FierceBiotech
@JohnCFierce: How can you highlight Irish takeover targets and not mention Shire in the lead? Jazz, Alkermes on top. Bloomberg story | Follow @JohnCFierce
@RyanMFierce: Medicines Co. wraps $240M deal to buy ProFibrix following PhIII success. Story | Follow @RyanMFierce
> A panel of outside experts at the FDA have turned thumbs down on an expanded approval of Otsuka's tolvaptan--Samsca--for autosomal dominant polycystic kidney disease. Story
> Following allegations of data tampering during studies of Novartis' ($NVS) Diovan, a government ministry in Japan is considering new rules that would penalize companies found guilty of falsifying trial results. Story
@FierceMedDev: Freedom Meditech lands $7M for diabetes device. Story | Follow @FierceMedDev
@DamianFierce: Latest in the BRCA battle: Ambry files antitrust suit against Myriad, claiming monopoly. Article | Follow @DamianFierce
@MichaelGFierce: Ocular Therapeutix nets FDA panel meeting for eye surgery hydrogel. More from FierceDrugDelivery | Follow @MichaelGFierce
> Volcano nudges revenue higher in Q2, but swings to a loss. Item
> Life Tech owes Enzo $48.6M after patent fight. Story
Pharma News
@FiercePharma: From FierceVaccines.com: GSK adding 2-D barcode to 4-in-1 flu vaccine packaging. Story | Follow @FiercePharma
@CarlyHFierce: Bayer says Eylea meets goal in diabetic macular edema trials. Release | Follow @CarlyHFierce
> Despite India's Herceptin patent moves, biosimilar rival isn't imminent. Report
> U.K. cost watchdogs nix Roche's new breast cancer drug Perjeta. Article
> Study: Pharma payments do sway doctors' prescribing habits. Story
Pharma Manufacturing News
@EricPFierce: Thermo Fisher has opened what it says is the first DPM plant in Singapore to tap growing biologics market. Article | Follow @EricPFierce
> Merck New Jersey plant to close in October. Story
> GSK adding 2-D barcodes to vaccine containers. Report
> Sanofi to make API for Vivus ED drug Stendra. Item
> Manufacturers' policies put hurt on execution drug supplies. Article
Biotech Research News
> Opioid receptor research could help shape drug development for addiction. More
> Plant-based inhibitor could halt HIV infection. Item
> NIH team sees diabetes drug as a possible tool for extending life. Story
> New hep C model could pave way for novel treatments. Article
> La Jolla, Kyowa Hakko Kirin partner on autoimmune disease drug discovery. More
And Finally… Researchers at the Salk Institute for Biological Studies have developed a new tool for protein engineering, offering a new way to add unbreakable bonds between two points in a protein or between two proteins. Release